MoneyWorks4Me

The sales for the June 2026 quarter moved up 32.32% to Rs. 14509.31 millions as compared to Rs. 10965.73 millions during the corresponding quarter last year.Net profit surges 62.97% to Rs. 2001.08  millions  from Rs. 1227.89 millions in the quarter ended June 2026.The company reported a good operating profit of 3646.15 millions compared to 2495.24 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 14509.31 10965.73 32.32 14509.31 10965.73 32.32 52431.88 43819.24 19.65
Other Income 250.32 215.24 16.30 250.32 215.24 16.30 2095.16 1188.07 76.35
PBIDT 3646.15 2495.24 46.12 3646.15 2495.24 46.12 13342.66 7656.44 74.27
Interest 327.76 205.38 59.59 327.76 205.38 59.59 1182.71 1129.62 4.70
PBDT 3318.39 2254.86 47.17 3318.39 2254.86 47.17 11909.24 6526.82 82.47
Depreciation 631.66 598.17 5.60 631.66 598.17 5.60 2467.33 2249.72 9.67
PBT 2686.73 1656.69 62.17 2686.73 1656.69 62.17 9441.91 4277.10 120.75
TAX 685.65 428.80 59.90 685.65 428.80 59.90 2112.32 1105.82 91.02
Deferred Tax -17.82 -11.23 58.68 -17.82 -11.23 58.68 -225.09 -21.25 959.25
PAT 2001.08 1227.89 62.97 2001.08 1227.89 62.97 7329.59 3171.28 131.12
Equity 1896.80 1895.08 0.09 1896.80 1895.08 0.09 1895.90 1894.83 0.06
PBIDTM(%) 25.13 22.75 10.44 25.13 22.75 10.44 25.45 17.47 45.64
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..